Revenue | ₹1,016.15Cr |
Net Profits | ₹257.49Cr |
Net Profit Margins | 25.34% |
Glaxosmithkline Pharmaceuticals Ltd’s revenue fell -3.22% since last year same period to ₹1,016.15Cr in the Q2 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 19.7% jump in its revenue since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 1.98% since last year same period to ₹257.49Cr in the Q2 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 25.6% jump in its net profits since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 5.37% since last year same period to 25.34% in the Q2 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 4.92% jumped in its net profit margins since last 3-months.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2025 was ₹1,016.15Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2025 was ₹257.49Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2025 was 25.34%.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2024 was ₹1,050.00Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2024 was ₹252.50Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q2 results 2024 was 24.05%.